Lipoprotein oxidation and gene expression in the artery wall: New opportunities for pharmacologic intervention in atherosclerosis
- 14 December 1993
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (12) , 2119-2126
- https://doi.org/10.1016/0006-2952(93)90599-r
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid networkThe FASEB Journal, 1992
- The Role of Oxidized Low-Density Lipoproteins in the Pathogenesis of AtherosclerosisAnnual Review of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Inhibition of IL-1β expression in THP-1 cells by probucol and tocopherolAtherosclerosis, 1991
- Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During AtherogenesisScience, 1991
- Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.Journal of Clinical Investigation, 1990
- Scavenging for receptorsNature, 1990
- Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat.Circulation Research, 1985